{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:20:49Z","timestamp":1759580449914},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1991,1]]},"DOI":"10.1016\/0145-2126(91)90464-5","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T13:46:32Z","timestamp":1082382392000},"page":"801-810","source":"Crossref","is-referenced-by-count":11,"title":["Interaction of various cytokines with interleukin 2 in the generation of killer cells from human bone marrow: Application in purging of leukemia"],"prefix":"10.1016","volume":"15","author":[{"given":"Bishan S.","family":"Charak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravin","family":"Agah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dixon","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitabha","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0145-2126(91)90464-5_BIB1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V74.3.1159.1159","article-title":"Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission on early relapse","volume":"74","author":"Rosenfeld","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0145-2126(91)90464-5_BIB2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood.V74.1.501.501","article-title":"Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia","volume":"74","author":"Rowley","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0145-2126(91)90464-5_BIB3","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood.V74.3.1152.1152","article-title":"Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) Ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma","volume":"74","author":"Preijers","year":"1989","journal-title":"Blood"},{"key":"10.1016\/0145-2126(91)90464-5_BIB4","first-page":"1199","article-title":"Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow","volume":"75","author":"Ball","year":"1990","journal-title":"Blood"},{"key":"10.1016\/0145-2126(91)90464-5_BIB5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V76.9.1723.1723","article-title":"Autologous bone marrow transplantation in high risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging","volume":"76","author":"Uckun","year":"1990","journal-title":"Blood"},{"key":"10.1016\/0145-2126(91)90464-5_BIB6","first-page":"4420","article-title":"Lysis of fresh and cultured autologous tumor by lymphocytes cultured in T-cell growth factor","volume":"41","author":"Lotze","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(91)90464-5_BIB7","series-title":"Lysis of natural killer-resistant fresh solid tumor cells by interleukin-2-activated autologous human peripheral blood lymphocytes","first-page":"1823","article-title":"Lymphokine activated killer cell phenomenon","volume":"155","author":"Grimm","year":"1982"},{"key":"10.1016\/0145-2126(91)90464-5_BIB8","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.4049\/jimmunol.143.9.3093","article-title":"Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation","volume":"143","author":"Agah","year":"1989","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(91)90464-5_BIB9","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/bjc.1989.324","article-title":"A phase I clinical trial of recominant interleukin 2 following high dose chemoradiotherapy for haematological malignancy: application to the elimination of minimal residual disease","volume":"60","author":"Gottlieb","year":"1989","journal-title":"Br. J. Cancer"},{"key":"10.1016\/0145-2126(91)90464-5_BIB10","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood.V76.11.2187.2187","article-title":"Bone marrow transplantation with interleukin-2 activated bone marrow followed by interleukin-2 therapy for acute myeloid leukemia in mice","volume":"76","author":"Charak","year":"1990","journal-title":"Blood"},{"key":"10.1016\/0145-2126(91)90464-5_BIB11","first-page":"193","article-title":"A novel approach to purging of leukemia by activation of bone marrow with interleukin-2","volume":"6","author":"Charak","year":"1990","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/0145-2126(91)90464-5_BIB12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1200\/JCO.1988.6.3.409","article-title":"Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 disseminated melanoma","volume":"6","author":"Mitchell","year":"1988","journal-title":"J. clin. Oncol."},{"key":"10.1016\/0145-2126(91)90464-5_BIB13","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.4049\/jimmunol.140.7.2312","article-title":"Transforming growth factor-\u03b21 and recombinant human tumor necrosis factor-\u03b1 reciprocally regulate the generation of lymphokine-activated killer cell activity","volume":"140","author":"Espevik","year":"1988","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(91)90464-5_BIB14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00205758","article-title":"TGF-\u03b2 inhibits the in vitro induction of lymphokine activated killing activity","volume":"27","author":"Grimm","year":"1988","journal-title":"Cancer Immun. Immunother."},{"key":"10.1016\/0145-2126(91)90464-5_BIB15","series-title":"Autocrine inhibition of cellular proliferation and differentiation to immune killer cells","first-page":"690","article-title":"Effects of transforming growth factor-\u03b2 on human lymphokine activated killer cell precursors","volume":"141","author":"Kasid","year":"1988"},{"key":"10.1016\/0145-2126(91)90464-5_BIB16","first-page":"149","article-title":"Human interleukin-1 is synergistic with interleukin-2 in the generation of lymphokine activated killer cells","volume":"49","author":"Crump","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(91)90464-5_BIB17","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.4049\/jimmunol.134.5.3124","article-title":"Generation of activated killer (AK) cells by recombinant interleukin-2 (r IL-2) in collaboration with interferon-\u03b3 (IFN-\u03b3)","volume":"134","author":"Itoh","year":"1985","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(91)90464-5_BIB18","first-page":"788","article-title":"Synergy of tumor necrosis factor and interleukin-2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin-2 in the generation of human lymphokine activated killer cell cytotoxicity","volume":"48","author":"Owen-Schaub","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(91)90464-5_BIB19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/320584a0","article-title":"Cachectin and tumor necrosis factor as two sides of the same biological coin","volume":"320","author":"Beutler","year":"1986","journal-title":"Nature (London)"},{"key":"10.1016\/0145-2126(91)90464-5_BIB20","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.4049\/jimmunol.138.6.1786","article-title":"Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-\u03b1: induction of TNF receptors on human T cells and TNF-\u03b1 mediated enhancement of T cell responses","volume":"138","author":"Scheurich","year":"1987","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(91)90464-5_BIB21","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.4049\/jimmunol.135.4.2492","article-title":"Effect of interleukin-2, interferon gamma and mitogens in the production of tumor necrosis factor alpha and beta","volume":"135","author":"Nedwin","year":"1985","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(91)90464-5_BIB22","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.4049\/jimmunol.143.10.3241","article-title":"Natural killer and lymphokine activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4","volume":"143","author":"Keever","year":"1989","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(91)90464-5_BIB23","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1084\/jem.170.5.1751","article-title":"Recombinant interleukin 4 suppresses the production of interferon-\u03b3 by human mononuclear cells","volume":"170","author":"Peleman","year":"1989","journal-title":"J. expl Med."},{"key":"10.1016\/0145-2126(91)90464-5_BIB24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0008-8749(87)90129-8","article-title":"The regulatory effect of adherent cells on lymphokine activated killer cells","volume":"110","author":"Ibayashi","year":"1987","journal-title":"Cell. Immun."},{"issue":"Suppl. 2","key":"10.1016\/0145-2126(91)90464-5_BIB25","first-page":"1","article-title":"Introduction and overview of hematopoietic growth factors","volume":"26","author":"Gabrilove","year":"1989","journal-title":"Semin. Hemat."},{"key":"10.1016\/0145-2126(91)90464-5_BIB26","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9343(90)90181-C","article-title":"Interleukin-1: biology, pathophysiology, and clinical prospects","volume":"89","author":"Platanias","year":"1990","journal-title":"Am. J. Med."},{"key":"10.1016\/0145-2126(91)90464-5_BIB27","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.4049\/jimmunol.136.12.4487","article-title":"The suppressive influences of human tumor necrosis factor on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-\u03b3","volume":"136","author":"Broxmeyer","year":"1986","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(91)90464-5_BIB28","first-page":"31","article-title":"Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation on enriched hematopoietic precursor cells","volume":"16","author":"Murphy","year":"1988","journal-title":"Expl Hemat."},{"key":"10.1016\/0145-2126(91)90464-5_BIB29","first-page":"2369","article-title":"Interleukin-1 as an autocrine growth factor for acute myeloid leukemia cells","volume":"86","author":"Cozzolino","year":"1989"},{"key":"10.1016\/0145-2126(91)90464-5_BIB30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1084\/jem.162.2.501","article-title":"Detection and characterization of high affinity plasma membrane receptors for human interleukin-1","volume":"162","author":"Dower","year":"1985","journal-title":"J. expl Med."},{"key":"10.1016\/0145-2126(91)90464-5_BIB31","first-page":"115","article-title":"Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma","volume":"6","author":"McGlave","year":"1990","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/0145-2126(91)90464-5_BIB32","first-page":"140","article-title":"Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor","volume":"7","author":"Agah","year":"1988","journal-title":"J. biol. Response Mod."},{"key":"10.1016\/0145-2126(91)90464-5_BIB33","first-page":"2245","article-title":"Successful therapy of natural killer-resistant pulmonary metastases by the synergism of \u03b3-interferon with tumor necrosis factor and interleukin-2 in mice","volume":"48","author":"Agah","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(91)90464-5_BIB34","first-page":"5959","article-title":"Potent graft antitumor effect in natural killer resistant disseminated tumors by transplantation of interleukin-2 activated syngeneic bone marrow in mice","volume":"49","author":"Agah","year":"1989","journal-title":"Cancer Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212691904645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212691904645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T01:25:25Z","timestamp":1705109125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212691904645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,1]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1991,1]]}},"alternative-id":["0145212691904645"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(91)90464-5","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[1991,1]]}}}